| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |